COMPANION-002
CTX-009-002
Biliary Tract Cancer (BTC)
A Phase 2/3 study in adults with unresectable, advanced, metastatic or recurrent biliary tract cancer who have received one prior systemic chemotherapy regimen. This randomized study assesses the efficacy and safety of CTX-009 in combination with paclitaxel versus paclitaxel alone as a second-line therapy. The primary outcome is Overall Response Rate (ORR).
CTX-009 is an investigational drug only – it is not currently approved by the FDA. This video is for general informational purposes only. For questions about our COMPANION-002 Trial please email CTX-009-002@compasstherapeutics.com.
Ver vídeo con subtítulos en español
CTX-009 is an investigational drug only – it is not currently approved by the FDA. This video is for general informational purposes only. For questions about our COMPANION-002 Trial please email CTX-009-002@compasstherapeutics.com.
CTX-009 is an investigational drug only – it is not currently approved by the FDA. This video is for general informational purposes only. For questions about our COMPANION-002 Trial please email CTX-009-002@compasstherapeutics.com.
COMPANION-003
CTX-009-003
Colorectal Cancer
A Phase 2 study enrolling patients with metastatic colorectal cancer who have received two or three prior systemic chemotherapy regimens. This study assesses the efficacy and safety of CTX-009. The primary outcome is ORR (Overall Response Rate).
CTX-471 + KEYTRUDA®
(pembrolizumab)
Solid Tumors
A Phase 1b arm enrolling patients who have metastatic or locally advanced non-small cell lung cancer, melanoma, small cell lung cancer, mesothelioma, and head and neck cancer who have progressed after treatment with a checkpoint inhibitor. Patients enrolled in the study are treated with a combination of CTX-471 + KEYTRUDA® (pembrolizumab) with the goal of restoring response.
COMPANION-002 Trial Locations
Please select a state.
Stanford Medicine Cancer Center
Palo Alto, California, United States, 94305
Currently Recruiting
Yasmeen Ahmed
yahmed@stanford.edu
Gregory Heestand, MD
University of California San Francisco
San Francisco, California, United States, 94143-1770
Currently Recruiting
Quincy Harris
Quincy.Harris@ucsf.edu
Maxine Hamilton Maxine.Hamilton2@ucsf.edu
Katie Kelley, MD
University of Southern California Norris Comprehensive Cancer Center
Currently Recruiting
Angelina Lee
Angelina.Lee@med.usc.edu
Anthony El-Khoueiry, MD
Johns Hopkins University
Baltimore, Maryland, United States, 21287
Currently Recruiting
Nilofer Azad, MD
202-365-0105
Nazad2@jhmi.edu
Christy Liu, Lead Nurse
xliu208@jhmi.edu
Nilofer Azad, MD
Massachusetts General Hospital
Boston, Massachusetts, United States, 02141
Currently Recruiting
Joanna Caufield, RN
jlcaufield@mgb.org
Ashley O’Meara
ALOMEARA@mgh.harvard.edu
Priyadarshini Pathak, MD
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905
Currently Recruiting
Clinical Trials Referral Office
855-776-0015
Nguyen Tran, MD
Memorial Medical Center
Las Cruces, New Mexico, United States, 88011
Currently Recruiting
glritcher@salud.unm.edu
lmancha@salud.unm.edu
Ursa Brown-Glaberman, MD
The University of New Mexico
Albuquerque, New Mexico, United States, 87131
Currently Recruiting
glritcher@salud.unm.edu
lmancha@salud.unm.edu
Ursa Brown-Glaberman, MD
Northwest Cancer Specialists, P.C.
Vancouver, Washington, United States, 98684
Not Yet Recruiting
Jennifer Thompson
jennifer.thompson@usoncology.com
David P Cosgrove, MD
AdventHealth Orlando
Orlando, Florida, United States, 32804
Currently Recruiting
Anh Le
407-303-8274
anh.le@adventhealth.com
Mohamedtaki Tejani, MD
Mayo Clinic Jacksonville
Jacksonville, Florida, United States, 32224
Currently Recruiting
Clinical Trials Referral Office
855-776-0015
Umair Majeed, MD
University of Florida
Gainesville, Florida, United States, 32611
Currently Recruiting
Allison Springer, MEd
sheehanallison@ufl.edu
Ilyas Sahin, MD
Gabrail Cancer Center
Canton, Ohio, United States, 44718
Currently Recruiting
Nashat Gabrail
research@gabrailcancercenter.com
Nashat Y Gabrail, MD
Cleveland Clinic
Cleveland, Ohio, United States, 44195
Currently Recruiting
Cancer Center Hotline
866-223-8100
Suneel Kamath, MD
University of Chicago
Chicago, Illinois, United States, 60637
Currently Recruiting
Hang Chang
773-702-3482
hchang@bsd.uchicago.edu
cancerclinicaltrials@bsd.uchicago.edu
Chih-Yi (Andy) Liao, MD
Northwestern University
Chicago, Illinois, United States, 60611
Currently Recruiting
Mohammed Abdulrahman Mohammed
mohammedabdulrahman.mohamm@northwestern.edu
Anastasia Papaioannou
630-938-2085
anastasia.papaioannou@nm.org
Aparna Kalyan, MD
Ochsner Clinic Foundation
New Orleans, Louisiana, United States, 70121
Currently Recruiting
Elise Curry, CRC
504-842-8084
elisemarie.curry@ochsner.org
Nancy Perez, CRC
504-842-0179
nancy.perez@ochsner.org
Lingling Du, MD
University of Arizona
Tucson, Arizona, United States, 85724-5024
Currently Recruiting
Brianna Loughran
bloughran@arizona.edu
Prisca Zimmerman
priscaz@arizona.edu
Rachna T Shroff, MD
Mayo Clinic Arizona
Phoenix, Arizona, United States, 85054
Currently Recruiting
Clinical Trials Referral Office
855-776-0015
Mitesh Borad, MD
Montefiore Medical Center
Bronx, New York, United States, 10461
Currently Recruiting
Chika Ekweghariri
cekweghari@montefiore.org
Fernand Bteich, MD
Roswell Park Comprehensive Cancer Center
Buffalo, New York, United States, 14263
Currently Recruiting
Mary Lynne Tarquini
marylynne.tarquini@roswellpark.org
Sarah Chatley
sarah.chatley@roswellpark.org
Renuka Iyer, MD
Columbia University
New York, New York, United States, 10032
Currently Recruiting
Kriti Bagri Manjrekar
kb3315@cumc.columbia.edu
Ruth White, MD
SCRI Oncology Partners
Nashville, Tennessee, United States, 37203
Currently Recruiting
Meredith P. Pelster, MD
University of Tennessee Medical Center
Knoxville, Tennessee, United States, 37920
Currently Recruiting
Dani Joyner, BSN, RN, OCN
865-305-3565
jdjoyner@utmck.edu
Saikrishna Gadde, MD
Rocky Mountain Cancer Centers, LLP
Aurora, Colorado, United States, 80012
Currently Recruiting
Jennifer Hege
jennifer.hege@usoncology.com
Sujatha Nallapareddy, MD
Texas Oncology – Northeast Texas
Tyler, Texas, United States, 75702
Currently Recruiting
Shelly K Maxfield
shelly.maxfield@usoncology.com
Donald A Richards, MD, PhD
Texas Oncology – San Antonio
San Antonio, Texas, United States, 78217
Currently Recruiting
Shannon Syring
Nathan Shumway, DO
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States, 77030
Currently Recruiting
GIClinicalTrials@mdanderson.org
Zishuo Ian Hu, MD
Texas Oncology – Dension
Denison, Texas, United States, 75020
Currently Recruiting
Jayne Mettetal
jayne.mettetal@usoncology.com
Amir Faridi, MD
Texas Oncology – Baylor Charles A. Sammons Cancer Center
Dallas, Texas, United States, 75246
Currently Recruiting
Christine Terraciano Christine.terraciano@usoncology.com
Andrew Scott Paulson, MD
Texas Oncology – Austin
Austin, Texas, United States, 78705
Currently Recruiting
Jennifer Rowan
jennifer.rowan@usoncology.com
Vivian Cline, MD
Rutgers Cancer Institute
New Brunswick, New Jersey, United States, 08854
Currently Recruiting
Lead Clinical Research Coordinator
perez11@cinj.rutgers.edu
Back-Up Clinical Research Coordinator
uq5@cinj.rutgers.edu
Howard Hochster, MD
Washington University School of Medicine, Siteman Cancer Center
Saint Louis, Missouri, United States, 63110
Currently Recruiting
David Timm
314-215-7337
Timmd@wustl.edu
Olivia Aranha, MD